Prostate Cancer

TRI researchers are dedicated to finding solutions to help the 20,000 plus Australian men diagnosed and 3,300 who will die from prostate cancer every year, and to improve clinical management of prostate cancer in Australia.

The following groups are undertaking prostate cancer research at TRI:

  • Led by Professor Colleen Nelson and based at TRI, the Australian Prostate Cancer Research Centre - Queensland (APCRC-Q) spans the spectrum of prostate cancer research - discovery, prognostic biomarker and therapeutic development - through the expertise and passion of a large, coordinated, multidisciplinary research team, underpinned by leading technology. For more information on APCRC-Q, please visit http://www.australianprostatecentre.org/.
  • UQDI’s Dr Michelle Hill is working on a prostate cancer diagnostic which could identify or predict metastisis, the process by which cancer spreads to other organs. Metastatic prostate cancer is more life-threatening and requires more aggressive treatment.
  • QUT's Associate Professor Jyotsna Batra and her team are working on ways to increase the accuracy of the Prostate Specific Antigen (PSA) test, the main tool used for prostate cancer screening. A/Prof Batra was named Cure Cancer Researcher of the Year in 2018
  • Professor Pamela Russell and her team are developing a combinations of diagnostics and therapy to develop 'theranostics' to improve diagnosis and treatment of prostate cancer. Read more

Key Researchers
Michelle M Hill
Pamela Russell
Brett Hollier
Colleen Nelson
Elizabeth Williams
Jyotsna Batra
Show More ...
Key Aims
  • Develop new therapies for advanced disease, with an emphasis on rationalised combination strategies with androgen targeted agents and prostate cancer progression pathways.
  • Identify, validate and develop biomarkers for genetic predisposition, prognostication to differentiate indolent from aggressive disease, therapeutic response indicators to inform treatment options and planning.
APCRC Laboratory
APCRC Laboratory
APCRC Laboratory
New treatments for advanced prostate cancer QUT’s Dr Lisa Philp is combining her knowledge of hormones and metabolism to develop a new treatment for late stage prostate cancer . Based at TRI...Read more
Anti-androgen therapy may fuel spread of bone tumours in advanced prostate cancer Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer which has spread to the bones...Read more
Drug research pivoted from prostate cancer to COVID-19 treatment Two drugs under development to treat aggressive prostate cancer will be tested to combat the deadliest response to COVID-19 infection...Read more
A lifetime dedicated to prostate and bladder cancer research A new, targeted antibody-based treatment and diagnostic for prostate and bladder cancers is one of several important outcomes from the...Read more
A new research grant will help researchers better understand and potentially treat prostate cancer, which has spread to the bones. Cure Cancer Australian, Cancer Australia and the Can Too Foundation...Read more
A/Prof Jyotsna Batra wins a 2019 Queensland Young Tall Poppy Science Award Congratulations to QUT’s Associate Professor Jyotsna Batra, who has been selected as an Outstanding Early Career...Read more
Using PROMs and PREMs to shape health and care for people with cancer Presented by visting fellow, Dame Prof Jessica Corner DBE, FMedSci Pro-Vice Chancellor for Research and Knowledge Exchange for...Read more
Movember 2018 Every year the Australian Prostate Cancer Research Centre Qld (APCRC-QLD) runs a series of fundraising events to raise money for the Movember Foundation. Wednesday 28 November - Pop U p...Read more
Dr Jyotsna Batra wins cure cancer award 2016 TRI Spore Grant winner , QUT’s Dr Jyotsna Batra, won a Cure Cancer award last night at the Australia's Researcher Showcase and 50th birthday...Read more
Community Conversations Prostate Cancer Foundation of Australia (PCFA) invites you to attend their free Community Conversations forum, to discuss the latest research and management of prostate cancer...Read more